Rawlins group_Human fetal lung tissue staining image showing alveolar development

Novel human lung organoids to study development and disease

08.12.22 Organoid modelling of human fetal lung development reveals mechanisms of lung patterning and disease processes.

A study from the Rawlins lab led by Kyungtae Lim has deciphered the role of cell-cell interactions in building the human lung gas exchange surface. The lab developed a new organoid system which also allowed them to identify transcription factor targets and to perform disease modelling. This has been a highly collaborative project, including with Alex Donovan from the Brand lab.

Lim K., Donovan A.P.A., Tang W., Sun D., He P., Teichmann S.A., Marioni J.C., Meyer K.B., Brand A.H., and Rawlins E.L. (2023). Organoid modelling of human fetal lung alveolar development reveals mechanisms of cell fate patterning and neonatal respiratory disease. Cell Stem Cell 30, 1-18. Published online December 8, 2022. DOI: 10.1016/j.stem.2022.11.013.

Graphical abstract of Organoid modelling of human fetal lung alveolar development reveals mechanisms of cell fate patterning and neonatal respiratory disease. Cell Stem Cell

Abstract from the paper

Variation in lung alveolar development is strongly linked to disease susceptibility. However, underlying cellular and molecular mechanisms are difficult to study in humans. We have identified an alveolar-fated epithelial progenitor in human fetal lungs, which we grow as self-organizing organoids that model key aspects of cell lineage commitment. Using this system, we have functionally validated cell-cell interactions in the developing human alveolar niche, showing that Wnt signaling from differentiating fibroblasts promotes alveolar-type-2 cell identity, whereas myofibroblasts secrete the Wnt inhibitor, NOTUM, providing spatial patterning. We identify a Wnt-NKX2.1 axis controlling alveolar differentiation. Moreover, we show that differential binding of NKX2.1 coordinates alveolar maturation, allowing us to model the effects of human genetic variation in NKX2.1 on alveolar differentiation. Our organoid system recapitulates key aspects of human fetal lung stem cell biology allowing mechanistic experiments to determine the cellular and molecular regulation of human development and disease.